|
|
ALPS Group Inc
NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/15/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization153.09 mln
Earnings Date05/29/2026
Key Fundamentals
EPS-0.02
RPS0.02
ROIC-36.89
ROA-36.40
EBITDA, mln-2.49
EV / EBITDA-62.41
EV / EBIT-62.41
Revenue, mln3.37
EV / Revenue46.03
Financial Strength
Altman Z-Score7.39
Piotroski F-Score
5
/ 9
Beneish M-Score-2.5
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
7.78% |
93
/ 100
 |
| 1 Month |
-11.49% |
16
/ 100
 |
| 2 Months |
-4.94% |
31
/ 100
 |
| 6 Months |
7.93% |
67
/ 100
 |
|
| |
